title: ["Mixed" and "miscellaneous" vulvovaginitis: diagnostics and therapy of vaginal administration of nystatin and nifuratel].
abstract: OBJECTIVE
  The evaluation of combined and miscellaneous vulvovaginal infections incidence and their treatment with combined vaginal products containing nifuratel and nystatin.
  
  
  METHODS
  Prospective study.
  
  
  METHODS
  Gynecologic outpatient department LEVRET, Prague; Laboratories of Microbiology AescuLab, Prague.
  
  
  METHODS
  70 consecutive patients were examined with complaint of vaginal fluor and/or pruritus. We established macroscopic features of fluor, pH, amine test and mounts stained with Giemsa and Gram. We qualified the cases with more diagnostic criteria (mycosis, lactobacillosis, anaerobic vaginosis, aerobic vaginitis) as combined infection, those with no diagnostic criteria as miscellaneous. We treated all patients with vaginal tablets nystatin + nifuratel (Macmiror complex). We prescribed clotrimazol cream, if pruritus was present. We evaluated withdrawals of symptoms and relapses during 3 months after treatment.
  
  
  RESULTS
  Combined infection was found in 21 patients from 70 (30%). The most frequent combination was that of mycosis and aerobic vaginitis (13/70, 18.6%) or mycosis and anaerobic vaginosis (4/70, 5.7%); 11 patients fulfilled criteria of no diagnosis. We concluded them as "miscelaneous". The treatment was successful in all cases, 10 women relapsed in 3 months.
  
  
  CONCLUSIONS
  Combined vaginal infection findings are present very often (30%), likewise miscellaneous ones (15%) occur. The treatment of these women in successful with vaginal tablets with nystatin + nifuratel.
authors.affiliation: Gynekologicko-porodnická ambulance LEVRET s.r.o., Praha.
authors.forename: P
authors.initials: P
authors.lastname: Cepický
authors.forename: J
authors.initials: J
authors.lastname: Malina
authors.forename: Z
authors.initials: Z
authors.lastname: Líbalová
authors.forename: M
authors.initials: M
authors.lastname: Kuzelová
mesh_terms: D000282:Administration, Intravaginal; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D000935:Antifungal Agents / Q000008:administration & dosage*; D000994:Antitrichomonal Agents / Q000008:administration & dosage*; D002181:Candidiasis, Vulvovaginal / Q000150:complications / Q000188:drug therapy; D003022:Clotrimazole / Q000008:administration & dosage; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008875:Middle Aged; D009545:Nifuratel; D009761:Nystatin / Q000008:administration & dosage*; D014247:Trichomonas Vaginitis / Q000150:complications / Q000188:drug therapy; D016585:Vaginosis, Bacterial / Q000150:complications / Q000188:drug therapy; D014848:Vulvovaginitis / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D000994:Antitrichomonal Agents; D004338:Drug Combinations; D009761:Nystatin; D003022:Clotrimazole; D009545:Nifuratel